J. Irani, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.1207-1215, 2003.

P. Brennan, O. Bogillot, and S. Cordier, Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studies, International Journal of Cancer, vol.61, issue.2, pp.289-94, 2000.
DOI : 10.1002/1097-0142(19880201)61:3<622::AID-CNCR2820610334>3.0.CO;2-J

J. Burch, T. Rohan, and G. Howe, Risk of bladder cancer by source and type of tobacco exposure: a case-control study. International journal of cancer The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies, Cancer, vol.448910, issue.43, pp.622-8630, 1989.

E. Imbernon, M. Goldberg, M. J. , G. Soit-ilg-a, and C. M. , Estimation du nombre de cas de cancers attribuables à des facteurs professionnels. Archives des maladies professionnelles et de médecine du travail, 2003.

P. Provenzano and P. Keely, The role of focal adhesion kinase in tumor initiation and progression, Cell Adhesion & Migration, vol.61, issue.4, pp.347-50, 2009.
DOI : 10.1088/0031-9155/45/6/308

L. Chen, J. Nergard, L. Ni, C. Rosser, and K. Chai, Long-Term Exposure to Cigarette Smoke Extract Induces Hypomethylation at the RUNX3 and IGF2-H19 Loci in Immortalized Human Urothelial Cells, PLoS ONE, vol.26, issue.5, p.65513, 2013.
DOI : 10.1371/journal.pone.0065513.s001

R. Brownson, J. Chang, J. Davis, E. White, T. Vaughan et al., Nutrient intake in relation to bladder cancer among middle-aged men and women. American journal of epidemiology Epub 1996/09/01 Use of permanent hair dyes and bladder-cancer risk Dietary soy and increased risk of bladder cancer: the Singapore Chinese Health Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Elevated risk of cancer of the urinary tract for alcohol drinkers: a meta-analysis, American journal of public health. International journal of cancer. Zeegers MP Cancer causes & control : CCC, vol.77144911112241010, issue.135, pp.1298-300485, 1987.

X. Wu, X. Lin, C. Dinney, J. Gu, H. Grossman et al., Genetic polymorphism in bladder cancer Frontiers in bioscience : a journal and virtual library Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study, BJU international, vol.122811529, issue.152, pp.192-213238, 2006.

J. Gu and X. Wu, Genetic susceptibility to bladder cancer risk and outcome. Personalized medicine, pp.365-74, 2011.
DOI : 10.2217/pme.11.15
URL : http://europepmc.org/articles/pmc3172962?pdf=render

J. Brierley, . Gm, C. Wittekind, S. Brookman-amissah, and J. Roigas, TNM classification of malignant tumors Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the, UICC International Union Against Cancer World Health Organisation classifications. European urology, vol.1857, issue.5, pp.850-807, 1973.

P. Humphrey, H. Moch, A. Cubilla, T. Ulbright, and V. Reuter, The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs???Part B: Prostate and Bladder Tumours, European Urology, vol.70, issue.1, pp.106-125, 2016.
DOI : 10.1016/j.eururo.2016.02.028

J. Irani, Treatment of non-muscle infiltrating tumours of the bladder] Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.248-53, 2009.

R. Sylvester, A. Van-der-meijden, and W. Oosterlinck, Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013, Epub 2006/01/31. 22. Babjuk M Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.466-471, 2006.

A. Witjes, J. Lebret, T. Comperat, and E. , Updated 2016 EAU Guidelines on Muscleinvasive and Metastatic Bladder Cancer Urinary tract infection and patient satisfaction after flexible cystoscopy and urodynamic evaluation, European urology. Urology, vol.715628, issue.3106, pp.462-7537, 2000.

T. Karmouni, K. Bensalah, A. A. Patard, J. Lobel, B. Guille et al., Role of antibiotic prophylaxis in ambulatory cystoscopy] Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie Comparison of screening methods in the detection of bladder cancer, Epub The Journal of urology, vol.112816123, issue.6201, pp.1239-41388, 1999.

Y. Miyoshi, J. Matsuzaki, and T. Miura, Evaluation of usefulness of urinary nuclear matrix protein 22 (NMP22) in the detection of urothelial transitional cell carcinoma], Hinyokika kiyo Acta urologica Japonica, vol.4711, issue.6, pp.379-83, 2001.

M. Paoluzzi, M. Cuttano, P. Mugnaini, F. Salsano, and P. Giannotti, Urinary dosage of nuclear matrix protein 22 (NMP22) like biologic marker of transitional cell carcinoma (TCC): a study on patients with hematuria. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, pp.13-808, 1999.

P. Quek, C. Chin, P. Lim, M. Sarosdy, P. Schellhammer et al., The role of BTA stat in clinical practice Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer, Annals of the Academy of Medicine, Singapore. The Journal of urology, vol.311816810, issue.325, pp.212-61950, 2002.

H. Grossman, V. Kannan, S. Bose, M. Marberger, and P. Conort, New methods for detection of bladder cancer Seminars in urologic oncology Low grade transitional cell carcinoma and instrument artifact. A challenge in urinary cytology Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer, Acta cytologica. European urology, vol.16213735, issue.3461, pp.17-22899, 1993.

U. Maier, R. Simak, N. Neuhold, E. Comperat, and N. Cowan, The clinical value of urinary cytology: 12 years of experience with 615 patients EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines, Journal of clinical pathology. European urology, vol.4865, issue.44, pp.314-7778, 1995.

J. Munoz and L. Ellison, Upper tract urothelial neoplasms: incidence and survival during the last 2 decades, The Journal of urology, vol.16410, issue.5, pp.1523-512, 2000.

M. Rink, V. Margulis, P. Karakiewicz, G. Novara, and S. Shariat, Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence, World journal of urology. European urology, vol.316110, issue.15, pp.141-51069, 2012.

W. Li, J. Shen, and C. Li, Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update, WHO classification of the renal tumors of the adults, pp.963-9997, 2004.

R. Abouassaly, S. Alibhai, N. Shah, N. Timilshina, N. Fleshner et al., Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma Epub 2010/07/22. 45 Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, Urology. Roupret M Babjuk M, Comperat E, vol.7640, issue.412, pp.895-9011629, 2010.
DOI : 10.1016/j.urology.2010.04.020

M. Aine, P. Eriksson, F. Liedberg, M. Hoglund, and G. Sjodahl, On Molecular Classification of Bladder Cancer: Out of One, Many, European Urology, vol.68, issue.6, pp.921-924, 2015.
DOI : 10.1016/j.eururo.2015.07.021

W. Choi, S. Porten, and S. Kim, Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer cell, pp.152-65, 2014.

Y. Choi, S. Lee, and J. Lee, Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10???17), British Journal of Cancer, vol.18, issue.2, pp.260-265, 2014.
DOI : 10.1093/annonc/mdl154

D. Mcconkey, W. Choi, A. Ochoa, A. Siefker-radtke, B. Czerniak et al., Therapeutic Opportunities in the Intrinsic Subtypes of Muscle-Invasive Bladder Cancer, The Cancer Genome Atlas Research N. Comprehensive molecular characterization of urothelial bladder carcinoma, pp.377-94, 2015.
DOI : 10.1016/j.hoc.2014.11.003

A. Robertson, J. Kim, and H. Al-ahmadie, FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder, Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. Cancer Res, vol.1716312, issue.323, pp.540-568108, 2003.

Y. Neuzillet, X. Paoletti, and S. Ouerhani, A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer Two molecular pathways to transitional cell carcinoma of the bladder Rhijn BW, Lurkin I, Chopin DK, et al. Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine, e48993. Epub 2012/12/29. 55. Spruck CH, 3rd Clinical cancer research : an official journal of the American Association for Cancer Research, pp.784-8257, 1994.

B. Vojtesek, J. Bartek, C. Midgley, D. Lane, K. Sullivan et al., An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53 Mechanisms of transcriptional regulation by p53. Cell death and differentiation. 2017 Frequent FGFR3 mutations in papillary noninvasive bladder (pTa) tumors, Journal of immunological methods. Am J Pathol, vol.151158, issue.58606, pp.237-441955, 1992.

J. Ho, E. Chapeaublanc, and L. Kirkwood, Deregulation of Rab and Rab effector genes in bladder cancer):e39469 Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas, 62. van Rhijn BW, van Tilborg AA, Lurkin I, et al. Novel fibroblast growth factor receptor 3, pp.18-20, 1999.

I. Lurkin and A. Van-exsel, Fadl-Elmula I. Chromosomal changes in uroepithelial carcinomas A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine Detection of bladder cancer recurrence by microsatellite analysis of urine, FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders. European journal of human genetics Epub 2005/08/09. 64. van Oers JM, pp.819-247743, 1997.

X. Li, T. Zhang, and J. Tang, Loss of STAG2 causes aneuploidy in normal human bladder cells Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes, Genetics and molecular research : GMR. Human molecular genetics, vol.14142326, issue.68811, pp.2638-461964, 2013.

G. Guo, X. Sun, and C. Chen, Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation, Nature Genetics, vol.1, issue.12, pp.1459-63, 2013.
DOI : 10.1093/nar/gki475

L. Mao, D. Lee, M. Tockman, Y. Erozan, F. Askin et al., Microsatellite alterations as clonal markers for the detection of human cancer Detection of bladder cancer by semi-automated microsatellite analysis of urine sediment, Proceedings of the National Academy of Sciences of the United States of America, pp.9871-519, 1994.

A. Schneider, S. Borgnat, and H. Lang, Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial, Cancer Res. Cancer, vol.609211, issue.744, pp.4617-22768, 2000.

J. Irani, New diagnostic tests for urothelial tumors of the bladder] Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, pp.481-487, 1998.

B. Konety, R. Getzenberg, K. Sighar, and M. Mohammed, Urine based markers of urological malignancy Epub 2001/02/15. 77. Lokeshwar VB, Soloway MS. Current bladder tumor tests: does their projected utility fulfill clinical necessity? The Journal of urology Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma, The Journal of urology. World journal of urology, vol.1216516532, issue.24, pp.600-111067, 1998.

S. Larre, P. Camparo, and E. Comperat, Diagnostic, Staging, and Grading of Urothelial Carcinomas from Urine: Performance of BCA-1, a Mini-Array Comparative Genomic Hybridisation???Based Test, European Urology, vol.59, issue.2, pp.250-257, 2010.
DOI : 10.1016/j.eururo.2010.10.007

L. Lunelli, . Co, P. Léon, C. Tassin, G. Sighar et al., Targeted Copy Number Variations Profiling of Non Muscle Invasive Bladder Urothelial Carcinoma Using BCA-1 Test on Urines Predicts High Grade Tumors, Urol Res Ther J, vol.1, issue.1, p.2017113, 2017.

M. Hoque, C. Lee, P. Cairns, M. Schoenberg, D. Sidransky et al., Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis High-throughput tissue microarray analysis of CMYC amplificationin urinary bladder cancer, Cancer Res. International journal of cancer, vol.6311730, issue.9606, pp.2216-22952, 2003.

J. Richter, F. Jiang, and J. Gorog, Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization. Cancer letters Chromosomal aberrations associated with invasion in papillary superficial bladder cancer, Cancer Res. The Journal of pathology, vol.571523818526, issue.842411, pp.2860-4230, 1997.

C. Couffignal, F. Desgrandchamps, and P. Mongiat-artus, The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study, Urology, vol.86, issue.6, pp.1185-90, 2015.
DOI : 10.1016/j.urology.2015.07.036

J. Gerdes, U. Schwab, H. Lemke, and H. Stein, Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation, International Journal of Cancer, vol.18, issue.1, pp.13-20, 1983.
DOI : 10.1177/28.8.7003001

L. Wang, C. Feng, and G. Ding, Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer, Tumor Biology, vol.161, issue.4, pp.2989-95, 2013.
DOI : 10.1016/S0002-9440(10)64396-9

L. Wang, C. Feng, G. Ding, Z. Zhou, H. Jiang et al., Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classification, Journal of BUON : official journal of the Balkan Union of Oncology, vol.18, issue.2, pp.420-424, 2013.

M. Enache, C. Simionescu, L. Lascu, C. Marcondes, F. Tuon et al., Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie Superficial papillary urothelial neoplasms of the bladder (PTA E PT1): correlation of expression of P53, KI-67 and CK20 with histologic grade, recurrence and tumor progression The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer, Ki67 and Bcl-2 immunoexpression in primitive urothelial bladder carcinoma, pp.521-5394, 1997.

A. Braithwaite, J. Royds, and P. Jackson, The p53 story: layers of complexity, Carcinogenesis, vol.26, issue.7, pp.1161-909, 2005.
DOI : 10.1056/NEJM199801153380307
URL : https://academic.oup.com/carcin/article-pdf/26/7/1161/7089399/bgi091.pdf

J. Amaral, J. Xavier, C. Steer, C. Rodrigues, B. Schlichtholz et al., The role of p53 in apoptosis Clinical implications of p53 mutation analysis in bladder cancer tissue and urine sediment by functional assay in yeast Black P. Frequent truncating mutations of STAG2 in bladder cancer, Epub 2010/03/03. 96, pp.145-522319, 2004.

M. Razzak, . Bladder, S. Zhang, and J. Bondaruk, STAG2 in the spotlight--have genomic studies identified a plausible biomarker? Nature reviews Urology Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior Scientific reports, p.67540714, 2013.

A. Koyuncuer, Immunohistochemical expression of p63, p53 in urinary bladder carcinoma, Indian Journal of Pathology and Microbiology, vol.56, issue.1, pp.10-15, 2013.
DOI : 10.4103/0377-4929.116141
URL : https://doi.org/10.4103/0377-4929.116141

R. Hegazy, M. Kamel, and E. Salem, The prognostic significance of p53, p63 and her2 expression in non-muscle-invasive bladder cancer in relation to treatment with bacille Calmette???Guerin, Arab Journal of Urology, vol.13, issue.3, pp.225-255, 2015.
DOI : 10.1016/j.aju.2015.05.001

M. Urist, D. Como, C. Lu, and M. , Loss of p63 Expression Is Associated with Tumor Progression in Bladder Cancer, The American Journal of Pathology, vol.161, issue.4, pp.1199-20609, 2002.
DOI : 10.1016/S0002-9440(10)64396-9
URL : http://europepmc.org/articles/pmc1867279?pdf=render

S. Rebouissou, I. Bernard-pierrot, and A. De-reynies, EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype, Science Translational Medicine, vol.115, issue.6, pp.244-91, 2014.
DOI : 10.1182/blood-2009-05-221275

W. Choi, B. Czerniak, and A. Ochoa, Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer, Nature Reviews Urology, vol.8, issue.7, pp.400-410, 2014.
DOI : 10.1073/pnas.0610292104

J. Warrick, M. Kaag, and J. Raman, FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma, Virchows Archiv, vol.158, issue.4, 2017.
DOI : 10.1016/j.cell.2014.06.049

D. Jones, M. Wade, and S. Nakjang, FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer, Oncotarget, vol.6, issue.30, pp.29782-94, 2015.
DOI : 10.18632/oncotarget.4927
URL : http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=4927&path%5B%5D=13001

X. Fu, R. Jeselsohn, and R. Pereira, FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer, Proceedings of the National Academy of Sciences, vol.17, issue.5, pp.6600-930, 2016.
DOI : 10.1200/JCO.1999.17.5.1474
URL : http://www.pnas.org/content/113/43/E6600.full.pdf

R. Mehta, R. Jain, and S. Leung, FOXA1 is an independent prognostic marker for ERpositive breast cancer. Breast cancer research and treatment, pp.881-90, 2011.
DOI : 10.1007/s10549-011-1482-6

S. Lerner, D. Mcconkey, and K. Hoadley, Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting, Bladder Cancer, vol.20, issue.24, pp.37-47, 2016.
DOI : 10.1158/1078-0432.CCR-14-0257
URL : http://content.iospress.com/download/bladder-cancer/blc150037?id=bladder-cancer%2Fblc150037

V. Joulin, D. Bories, and J. Eleouet, A T-cell specific TCR delta DNA binding protein is a member of the human GATA family, The EMBO journal, vol.10, issue.7, pp.1809-1825, 1991.

E. Van-allen, K. Mouw, and P. Kim, Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma. Cancer discovery, pp.1140-53, 2014.

D. Lindgren, A. Frigyesi, and S. Gudjonsson, Combined Gene Expression and Genomic Profiling Define Two Intrinsic Molecular Subtypes of Urothelial Carcinoma and Gene Signatures for Molecular Grading and Outcome, Cancer Research, vol.70, issue.9, pp.3463-72, 2010.
DOI : 10.1158/0008-5472.CAN-09-4213
URL : http://cancerres.aacrjournals.org/content/canres/70/9/3463.full.pdf

G. Sjodahl, Molecular Subtype Profiling of Urothelial Carcinoma Using a Subtype-Specific Immunohistochemistry Panel, Methods in molecular biology, vol.242, issue.1, pp.53-64, 2017.
DOI : 10.1002/path.4886

G. Sjodahl, P. Eriksson, F. Liedberg, and M. Hoglund, Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification, The Journal of Pathology, vol.348, issue.1, pp.113-138, 2017.
DOI : 10.1126/science.1262110

A. Bankfalvi, R. Simon, and B. Brandt, Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use, Histopathology, vol.74, issue.5, pp.411-420, 2000.
DOI : 10.1038/bjc.1996.439

D. Solomon, J. Kim, and J. Bondaruk, Frequent truncating mutations of STAG2 in bladder cancer, Nature Genetics, vol.474, issue.12, pp.1428-1458, 2013.
DOI : 10.1158/0008-5472.CAN-08-3272
URL : http://europepmc.org/articles/pmc3875130?pdf=render